Renaissance Technologies - HEPION PHARMACEUTICALS INC ownership

HEPION PHARMACEUTICALS INC's ticker is HEPA and the CUSIP is 426897104. A total of 47 filers reported holding HEPION PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 1.20 and the average weighting 0.0%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of HEPION PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2023$221
+198.6%
284,300
+15.8%
0.00%
Q4 2022$74
-99.9%
245,600
+5.8%
0.00%
Q3 2022$117,000
-12.7%
232,100
-1.1%
0.00%
Q2 2022$134,000
-17.8%
234,600
+85.3%
0.00%
Q1 2022$163,000
+186.0%
126,600
+151.7%
0.00%
Q4 2021$57,000
-80.3%
50,300
-68.1%
0.00%
Q1 2021$290,000
-59.8%
157,500
-52.1%
0.00%
-100.0%
Q4 2020$721,000
+212.1%
329,022
+664.5%
0.00%
Q4 2019$231,00043,0390.00%
Other shareholders
HEPION PHARMACEUTICALS INC shareholders Q1 2021
NameSharesValueWeighting ↓
SABBY MANAGEMENT, LLC 57,309$178,0000.03%
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC 15,552$48,0000.00%
Squarepoint Ops LLC 15,524$48,0000.00%
ExodusPoint Capital Management, LP 11,632$36,0000.00%
BANK OF AMERICA CORP /DE/ 33,215$103,0000.00%
WELLS FARGO & COMPANY/MN 57$00.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 15,786$49,0000.00%
MILLENNIUM MANAGEMENT LLC 29,233$91,0000.00%
MORGAN STANLEY 54$00.00%
View complete list of HEPION PHARMACEUTICALS INC shareholders